Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy
Irish Journal of Medical Science (1971 -) · 2024
DOI: 10.1007/s11845-024-03751-0 ↗Kurz gefasst
Fallbericht in der Zeitschrift Irish Journal of Medical Science (1971 -), 2024. Verfasst von Jason Patterson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Belfast City Hospital, Belfast, Northern Ireland, UK. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, STAT5 Transcription Factor, Sulfonamides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Acute promyelocytic leukaemia (APL) with a STAT5b::RARα gene fusion is an extremely rare subtype of APL characterised by resistance to conventional therapies and extremely poor prognosis. This case highlights that whilst APL with variant RARα translocations are rare, they do pose significant challenges both diagnostically and in their clinical management. This case, in the first instance, demonstrates the importance of using a combination of molecular techniques including next generation sequencing (NGS) for diagnosis particularly in morphological and immunophenotypic typical APL which appears negative by confirmatory testing. Secondly, our patient represents, to the best of our knowledge, the first documented example of this rare disease that has been managed with, and shown sensitivity to low-dose cytarabine (LDAC) in combination with venetoclax (Ven). This case demonstrates that although treatment options are extremely limited for patients not eligible for intensive chemotherapy non-intensive options do show increasing promise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematology, Belfast City Hospital, Belfast, Northern Ireland, UK.
- Cancer Genetics, Guy's Hospital, Synnovis, London, UK.
- Precision Medicine Centre, Queen's University Belfast, Belfast, Northern Ireland, UK.
- Regional Molecular Diagnostics Service, Belfast City Hospital, Belfast, Northern Ireland, UK.
- Centre for Medical Education, Queen's University Belfast, Belfast, Northern Ireland, UK. M.Mcmullin@qub.ac.uk.
Zitieren
APA
Patterson, J., Clarke, K., Mokretar, K., Maurya, M., Logan, A., Cunningham, N., Catherwood, M., & McMullin, M. F. (2024). Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-024-03751-0
Vancouver
Patterson J, Clarke K, Mokretar K, Maurya M, Logan A, Cunningham N, et al. Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy. Irish Journal of Medical Science (1971 -). 2024. doi:10.1007/s11845-024-03751-0
BibTeX
@article{Patterson2024,
author = {Patterson, Jason and Clarke, Kathryn and Mokretar, Katya and Maurya, Manisha and Logan, Amy and Cunningham, Nicholas and Catherwood, Mark and McMullin, Mary Frances},
title = {Treatment of a STAT5b::RARα positive case of APL in a patient not eligible for intensive chemotherapy},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2024},
doi = {10.1007/s11845-024-03751-0}
}
EUVIMED